PIL against Covaxin trial on 2-18 age group: HC seeks Centre’s stand
New Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetails
New Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetailsNew Delhi: After the alleged death of a volunteer enrolled in Bharat Biotech's Covaxin clinical trial in Bhopal, the Hyderabad-based ...
Read moreDetails
By Dilip Cherian A 10-officer reshuffle at the Additional Secretary level may look like routine housekeeping, but if you look...
Read moreDetails
Lately, the Supreme Court’s intervention in high-profile cases does not necessarily arouse confidence and reassurance that wrongs may be righted....
Read moreDetails
The recent meeting between US President Donald Trump and Chinese President Xi Jinping turned out to be a rather tame...
Read moreDetails
After remaining deafeningly silent on a media report casting serious doubts about the fairness and functioning of the Election Commission...
Read moreDetails